Ernst Heinen
Corporate Officer/Principal bei ARATANA THERAPEUTICS INC
Profil
Ernst Heinen is currently the Chief Development Officer at Aratana Therapeutics, Inc. He previously worked as a Director at the Kansas City Area Development Council and the Center For Animal Health Innovation.
Prior to that, he was the Vice President of Research and Development at Bayer Animal Health from 1990 to 2012.
He obtained his undergraduate and doctorate degrees from the University of Giessen.
Aktive Positionen von Ernst Heinen
| Unternehmen | Position | Beginn |
|---|---|---|
| ARATANA THERAPEUTICS INC | Corporate Officer/Principal | 05.03.2014 |
Ehemalige bekannte Positionen von Ernst Heinen
| Unternehmen | Position | Ende |
|---|---|---|
Bayer Animal Health
 Bayer Animal Health Pharmaceuticals: MajorHealth Technology Bayer Animal Health provides medical healthcare for livestock. The company is headquartered in Shawnee Mission, KS. | Chief Tech/Sci/R&D Officer | - |
Kansas City Area Development Council
 Kansas City Area Development Council Miscellaneous Commercial ServicesCommercial Services The Kansas City Area Development Council (KCADC) is a resource for businesses and individuals looking to relocate to the greater Kansas City area. The private company is based in Kansas City, MO. The company's focus is on providing assistance to those seeking to move their businesses or careers to the region. | Director/Board Member | - |
| Center For Animal Health Innovation | Director/Board Member | - |
Ausbildung von Ernst Heinen
| University of Giessen | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 4 |
|---|---|
Aratana Therapeutics, Inc.
 Aratana Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Aratana Therapeutics, Inc. engages in the development and commercialization of pet therapeutics. Its portfolio includes NOCITA, ENTYCE, and GALLIPRANT. NOCITA (bupivacaine liposome injectable suspension) acts as a local post-operative analgesia for cranial cruciate ligament surgery in dogs, and as a peripheral nerve block to provide regional post-operative analgesia following onychectomy in cats. ENTYCE(capromorelin oral solution) is intended for appetite stimulation in dogs. GALLIPRANT (grapiprant tablets) is for the control of pain and inflammation associated with osteoarthritis in dogs. The company was founded by Linda Rhodes and Steven St. Peter on December 1, 2010 and is headquartered in Leawood, KS. | Health Technology |
Kansas City Area Development Council
Kansas City Area Development Council Miscellaneous Commercial ServicesCommercial Services The Kansas City Area Development Council (KCADC) is a resource for businesses and individuals looking to relocate to the greater Kansas City area. The private company is based in Kansas City, MO. The company's focus is on providing assistance to those seeking to move their businesses or careers to the region. | Commercial Services |
Bayer Animal Health
Bayer Animal Health Pharmaceuticals: MajorHealth Technology Bayer Animal Health provides medical healthcare for livestock. The company is headquartered in Shawnee Mission, KS. | Health Technology |
| Center For Animal Health Innovation |
